5E Advanced Materials, Inc. — Form 10-Q Summary
Period: The filing covers the quarter ended March 31, 2023 (the third quarter of fiscal 2023), with nine-month comparisons to March 31, 2022. This differs from the supplied “2021 Q3” metadata. The filing was signed May 15, 2023.
Business context
5E is developing the Fort Cady boron and lithium project in California and has not generated operating revenue. Its near-term focus is commissioning a small-scale facility and advancing plans for larger-scale production.
Key financial results and position
| Metric | Three months ended March 31 | Nine months ended March 31 |
|---|---|---|
| Revenue | None | None |
| Operating expenses | $8.3 million in 2023; $33.0 million in 2022 | $28.0 million in 2023; $54.5 million in 2022 |
| Operating loss | $8.3 million in 2023; $33.0 million in 2022 | $28.0 million in 2023; $54.5 million in 2022 |
| Net loss | $10.1 million in 2023; $33.0 million in 2022 | $20.4 million in 2023; $53.5 million in 2022 |
| Loss per share | $0.23 in 2023; $0.79 in 2022 | $0.47 in 2023; $1.33 in 2022 |
Margins are not meaningful because the company reported no revenue. For the nine months, operating cash used was $24.1 million, investing cash used was $30.0 million, and financing provided $59.3 million. Cash was $36.2 million at March 31, 2023, versus $31.1 million at June 30, 2022; working capital was $26.6 million. Construction in progress rose to $61.5 million from $25.6 million.
Gross debt was $61.9 million, primarily the $60 million senior secured convertible note plus accrued note interest; reported long-term debt, net, was $36.2 million after unamortized discount and issuance costs. The note matures in August 2027, bears 4.5% cash or 6.0% in-kind interest, and includes a $10 million minimum cash covenant.
Changes versus prior comparable periods
- Reported losses narrowed substantially, principally because prior-year general and administrative expense included large one-time costs associated with the public-company preparation, reorganization and consulting fees. G&A fell to $6.0 million from $30.8 million for the quarter and to $18.6 million from $44.5 million for nine months.
- Nine-month results included an $11.7 million noncash derivative gain related to the convertible note. The conversion-feature derivative was derecognized and transferred to additional paid-in capital in the December 2022 quarter; no future gains or losses on that derivative are expected.
- Interest expense increased with the convertible note, including debt discount and issuance-cost amortization. Nine-month net interest expense was $5.0 million.
- The company recorded a $0.9 million impairment after allowing its Elementis mineral lease to expire on March 31, 2023.
Outlook, risks and unusual items
- Construction of the small-scale facility was substantially complete, with commissioning underway. Initial boric acid production remained subject to successful commissioning and final EPA authorization under the Underground Injection Control Permit.
- The updated technical report describes a phased larger-scale plan: Phase 1 targets 90,000 short tons of boric acid and 1,100 short tons of lithium carbonate by Q2 2026; Phases 2 and 3 target incremental capacity in Q4 2028 and Q2 2031. These are targets, not assured outcomes.
- Management’s forecast showed available liquidity falling below the $10 million covenant threshold in the latter part of calendar 2023. The company stated that additional financing is needed, and that a covenant default not cured within 30 days could make the convertible note immediately payable. The filing concludes substantial doubt exists about the company’s ability to continue as a going concern.
- Purchase-order commitments totaled $16.2 million, of which approximately $8.7 million was recorded in liabilities; most were expected to be settled by June 30, 2023. Management cited higher third-party construction estimates, inflation, and financing availability as risks.
- New CEO Susan Seilheimer Brennan began April 24, 2023. The company said she initiated administrative and fixed-cost reductions and planned to relocate headquarters to California.
- A previously identified material weakness in accounting-system access controls had been addressed in design, but management had not completed sufficient operating testing. Disclosure controls and procedures were deemed ineffective as of March 31, 2023.
Important facts for investors to verify
- Whether the company secured additional funding and maintained compliance with the $10 million cash covenant.
- Whether EPA authorization and commissioning enabled small-scale facility operations, and on what timing and cost.
- Whether updated construction estimates, remaining commitments and planned cost reductions changed the cash runway.
- Whether management completed testing and remediation of the material weakness in internal controls.
- Whether production targets and technical-report assumptions remain achievable; the filing provides no operating revenue or demonstrated commercial production.